At the 2025 China (Suzhou) Innovation Drug Medical Congress and CMAC Annual Meeting held today, Sophia Huang, General Manager of Beijing BrilliantMed Pharma Tech Co., Ltd., provided a detailed interpretation of the new policies for the expanded implementation of eCTD (Electronic Common Technical Document). According to Announcement No. 10 of 2025, starting from January 27, 2025, eCTD submissions will cover clinical trial applications for chemical drugs ...